These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25978399)

  • 21. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K; Hori S
    Curr Eye Res; 2011 Mar; 36(3):256-63. PubMed ID: 21275514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vitreous body and retinal vein occlusion].
    Bertelmann T; Bertelmann I; Szurman P; Mester U; Schmidt J; Sekundo W; Mennel S
    Ophthalmologe; 2014 Dec; 111(12):1178-82. PubMed ID: 24942219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases.
    Leizaola-Fernández C; Suárez-Tatá L; Quiroz-Mercado H; Colina-Luquez J; Fromow-Guerra J; Jiménez-Sierra JM; Guerrero-Naranjo JL; Morales-Cantón V
    BMC Ophthalmol; 2005 May; 5():10. PubMed ID: 15943889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion.
    Wen J; Jiang Y; Zheng X; Zhou Y
    Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Tatsugawa M; Shimada K; Eguchi S
    Retina; 2012 Jan; 32(1):86-91. PubMed ID: 21866074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical macular decompression for macular edema in retinal vein occlusion.
    Mandelcorn MS; Mandelcorn E; Guan K; Adatia FA
    Can J Ophthalmol; 2007 Feb; 42(1):116-22. PubMed ID: 17361252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vitreomacular interface in retinal vein occlusion.
    Bertelmann T; Kičová N; Messerschmidt-Roth A; Irle S; Sekundo W; Mennel S
    Acta Ophthalmol; 2011 Jun; 89(4):e327-31. PubMed ID: 21310017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreous changes and macular edema in central retinal vein occlusion.
    Kado M; Jalkh AE; Yoshida A; Takahashi M; Wazen N; Trempe CL; Schepens CL
    Ophthalmic Surg; 1990 Aug; 21(8):544-9. PubMed ID: 2234801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.
    Campochiaro PA; Bhisitkul RB; Shapiro H; Rubio RG
    Ophthalmology; 2013 Apr; 120(4):795-802. PubMed ID: 23260261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab.
    Funk M; Kriechbaum K; Prager F; Benesch T; Georgopoulos M; Zlabinger GJ; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1025-32. PubMed ID: 19060280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
    Yoshimura T; Sonoda KH; Sugahara M; Mochizuki Y; Enaida H; Oshima Y; Ueno A; Hata Y; Yoshida H; Ishibashi T
    PLoS One; 2009 Dec; 4(12):e8158. PubMed ID: 19997642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal vein occlusion and the optic disk.
    Hayreh SS; Zimmerman MB; Podhajsky PA
    Retina; 2012; 32(10):2108-18. PubMed ID: 22914682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion.
    Zeng Y; Cao D; Yu H; Zhuang X; Yang D; Hu Y; He M; Zhang L
    Mol Vis; 2019; 25():756-765. PubMed ID: 31814701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusion.
    Tuuminen R; Loukovaara S
    Eye (Lond); 2014 Sep; 28(9):1095-9. PubMed ID: 24946846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor upregulation in human central retinal vein occlusion.
    Pe'er J; Folberg R; Itin A; Gnessin H; Hemo I; Keshet E
    Ophthalmology; 1998 Mar; 105(3):412-6. PubMed ID: 9499769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radial optic neurotomy in ischemic central retinal vein occlusion].
    Lerche RC; Richard G
    Klin Monbl Augenheilkd; 2005 Feb; 222(2):134-41. PubMed ID: 15719318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalent misconceptions about acute retinal vascular occlusive disorders.
    Hayreh SS
    Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal thrombin activity is elevated in retinal vein occlusion.
    Bertelmann T; Stief T; Sekundo W; Mennel S; Nguyen N; Koss MJ
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):654-9. PubMed ID: 24625582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.